Dietary histone deacetylase inhibitors: From cells to mice to man
- 5 May 2007
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 17 (5), 363-369
- https://doi.org/10.1016/j.semcancer.2007.04.001
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Discovery and development of SAHA as an anticancer agentOncogene, 2007
- The Epigenomics of CancerCell, 2007
- Epigenetic alchemy for cell fate conversionCurrent Opinion in Genetics & Development, 2006
- Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis inApcminmiceThe FASEB Journal, 2006
- Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?Carcinogenesis: Integrative Cancer Research, 2005
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD MacrophagesThe Journal of Experimental Medicine, 2004
- A Novel Mechanism of Chemoprotection by SulforaphaneCancer Research, 2004
- Diallyl disulfide (DADS) increases histone acetylation and p21waf1/cip1 expression in human colon tumor cell linesCarcinogenesis: Integrative Cancer Research, 2004
- Response to histone deacetylase inhibition of novel PML/RARα mutants detected in retinoic acid–resistant APL cellsBlood, 2002